- 专利标题： APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
-
申请号： US17938835申请日： 2022-10-07
-
公开(公告)号： US20230143532A1公开(公告)日： 2023-05-11
- 发明人: Milan Bruncko , Hong Ding , George A. Doherty , Steven W. Elmore , Lisa A. Hasvold , Laura Hexamer , Aaron R. Kunzer , Xiaohong Song , Andrew J. Souers , Gerard M. Sullivan , Zhi-Fu Tao , Gary T. Wang , Le Wang , Xilu Wang , Michael D. Wendt , Robert Mantei , Todd M. Hansen
- 申请人： AbbVie Inc. , Genentech, Inc. , The Walter and Eliza Hall Institute of Medical Research
- 申请人地址： US IL North Chicago
- 专利权人： AbbVie Inc.,Genentech, Inc.,The Walter and Eliza Hall Institute of Medical Research
- 当前专利权人： AbbVie Inc.,Genentech, Inc.,The Walter and Eliza Hall Institute of Medical Research
- 当前专利权人地址： US IL North Chicago; US CA South San Francisco; AU Parkville
- 主分类号： C07D401/12
- IPC分类号： C07D401/12 ; C07D401/14 ; C07D519/00 ; C07D471/04 ; C07D209/82 ; C07D403/12 ; A61K31/496
摘要：
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
公开/授权文献
信息查询
